Recently, the news around infectious diseases have been dismal at best: rising cases of measles in the US, a growing shortage of Ebola vaccines in the Congo and increasing antimicrobial resistance in the UK. But last week, some good news: the US Food and Drug Administration authorized the marketing of the first diagnostic assay for Zika virus — the insidious mosquito-borne infection.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,